Special funding for research into COVID-19 vaccines and pharmaceutical development

19 May 2020
2 June 2020 at 16.15 Finnish time
EUR 10 million
1 Jan 2020–31 Dec 2022 (may start retroactively)
Pending
  • Total funding up to EUR 1.7 million per project
  • Applied for by independent researcher or consortium applying for funding to hire a research team f

This is a special call for research into COVID-19-related vaccine and pharmaceutical development. The call is aimed at preventing adverse health effects of the COVID-19 pandemic and/or at supporting the treatment of COVID-19 cases. Due to the urgency of the objective, the funding is primarily targeted at projects in which research is already under way.

In addition to a doctoral degree, the principal investigator (PI) of the proposed project must also have other significant scientific merits. Usually the PI is a researcher at the professor or docent (adjunct professor) level. The funding can be applied for by individual research teams or consortia composed of two or several research teams.

At the core of the Academy of Finland’s activities is to provide funding for excellent scientific research. The research we fund is also expected to have high scientific and social impact. The results of Academy-funded projects must be made public and they must be produced following good scientific practice. In other words, the research must be ethical, follow the principles of sustainable development and make its results, material and data openly accessible. Equality and non-discrimination must also be considered.

Before you fill in the application in the online services (SARA), carefully read the call text and the ‘Read more’ section, especially the funding terms and conditions.

If the call text and the funding terms and conditions conflict, the terms and conditions should always be considered primary. If the translated English or Swedish version of the call text is in conflict with the Finnish call text, the Finnish version should always be considered primary.

Read the full call text on this page. Click on the link below to print the text or save it in PDF format.

Do you have questions or feedback for us?